Over the last 7 days, the Biotech industry has dropped 1.9%, driven by a pullback from Genus of 3.8%. Meanwhile, Faron Pharmaceuticals Oy actually outperformed within the industry, gaining 30% in the last week. The industry has fallen 29% in the last year. As for the next few years, earnings are expected to grow by 19% per annum.
Has the U.K. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 19 Mar 2024 | UK£3.0b | UK£897.7m | -UK£203,616,909.25 | 33.3x | -14.9x | 3.4x |
Thu, 15 Feb 2024 | UK£3.3b | UK£913.5m | -UK£198,242,013.35 | 31x | -16.8x | 3.6x |
Sat, 13 Jan 2024 | UK£6.3b | UK£1.3b | -UK£245,123,674.00 | 37.6x | -25.9x | 5x |
Mon, 11 Dec 2023 | UK£6.2b | UK£1.3b | -UK£245,939,365.00 | 36.9x | -25.1x | 4.9x |
Wed, 08 Nov 2023 | UK£6.4b | UK£1.3b | -UK£243,321,128.00 | 38.5x | -26.2x | 5x |
Fri, 06 Oct 2023 | UK£6.4b | UK£1.3b | -UK£251,229,291.00 | 38.4x | -25.7x | 5x |
Sun, 03 Sep 2023 | UK£6.7b | UK£1.3b | -UK£205,920,114.00 | 23.6x | -32.4x | 5.3x |
Tue, 01 Aug 2023 | UK£6.9b | UK£1.3b | -UK£208,653,840.00 | 23.6x | -33.1x | 5.5x |
Thu, 29 Jun 2023 | UK£6.7b | UK£1.3b | -UK£209,044,141.00 | 23.9x | -32x | 5.3x |
Sat, 27 May 2023 | UK£7.0b | UK£1.3b | -UK£205,119,176.00 | 23.3x | -34x | 5.5x |
Mon, 24 Apr 2023 | UK£7.2b | UK£1.2b | -UK£156,309,305.00 | 23.5x | -46x | 5.8x |
Wed, 22 Mar 2023 | UK£7.2b | UK£1.2b | -UK£155,795,009.00 | 25.3x | -46.1x | 5.8x |
Fri, 17 Feb 2023 | UK£7.4b | UK£1.2b | -UK£150,075,119.00 | 28.1x | -49.4x | 6.3x |
Sun, 15 Jan 2023 | UK£7.7b | UK£1.2b | -UK£140,681,116.00 | 28.5x | -54.7x | 6.6x |
Tue, 13 Dec 2022 | UK£7.2b | UK£1.2b | -UK£136,959,345.00 | 25x | -52.5x | 6.2x |
Thu, 10 Nov 2022 | UK£7.8b | UK£1.2b | -UK£141,258,899.00 | 23.4x | -55.2x | 6.7x |
Sat, 08 Oct 2022 | UK£7.2b | UK£1.2b | -UK£149,697,721.00 | 26.4x | -48.4x | 6.2x |
Mon, 05 Sep 2022 | UK£7.0b | UK£1.1b | -UK£146,610,750.00 | 34.3x | -48x | 6.3x |
Wed, 03 Aug 2022 | UK£7.3b | UK£1.1b | -UK£199,929,586.00 | 37.7x | -36.4x | 6.5x |
Fri, 01 Jul 2022 | UK£6.8b | UK£1.1b | -UK£167,287,250.00 | 35.7x | -40.8x | 6.1x |
Sun, 29 May 2022 | UK£7.2b | UK£1.1b | -UK£146,482,002.00 | 38.9x | -49.1x | 6.5x |
Tue, 26 Apr 2022 | UK£7.2b | UK£1.1b | -UK£91,865,999.00 | 37.5x | -78.6x | 6.6x |
Thu, 24 Mar 2022 | UK£7.3b | UK£1.1b | -UK£77,066,195.00 | 42.7x | -95.3x | 6.7x |
Sat, 19 Feb 2022 | UK£8.2b | UK£1.1b | -UK£119,739,479.00 | 34.4x | -68.3x | 7.5x |
Mon, 17 Jan 2022 | UK£9.7b | UK£1.1b | -UK£123,388,341.00 | 47.3x | -78.3x | 8.9x |
Wed, 15 Dec 2021 | UK£10.9b | UK£1.1b | -UK£121,130,360.00 | 49.3x | -89.7x | 10x |
Fri, 12 Nov 2021 | UK£12.0b | UK£1.1b | -UK£149,906,152.00 | 70.1x | -79.8x | 11x |
Sun, 10 Oct 2021 | UK£11.8b | UK£1.1b | -UK£148,479,118.00 | 68.8x | -79.6x | 10.7x |
Tue, 07 Sep 2021 | UK£12.8b | UK£1.1b | -UK£143,503,184.62 | 56.3x | -89.3x | 12.2x |
Thu, 05 Aug 2021 | UK£12.0b | UK£1.0b | -UK£172,541,949.91 | 29.9x | -69.5x | 11.7x |
Sun, 09 May 2021 | UK£11.5b | UK£1.0b | -UK£166,311,048.52 | 30.3x | -69.3x | 11.4x |
-65x
Which industries have driven the changes within the U.K. Healthcare industry?
GB Market | 0.54% | |
Healthcare | -1.35% | |
Biotech | -2.45% | |
Biotech | -2.45% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
FARN Faron Pharmaceuticals Oy | UK£1.75 | 29.6% +UK£27.5m | -44.4% | PE-4.6x | |
PRTC PureTech Health | UK£2.04 | 4.0% +UK£21.1m | 0.5% | PS59.8x | |
AREC Arecor Therapeutics | UK£1.48 | 11.3% +UK£4.6m | -43.3% | PS13.4x | |
4BB 4basebio | UK£9.75 | 3.2% +UK£3.8m | 43.4% | PS352.7x | |
ETX e-therapeutics | UK£0.13 | 2.0% +UK£1.5m | -6.4% | PS221.3x |